SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivo Bio Tech informs about clarification on price movement

07 May 2021 Evaluate
With reference to the email dated 7 th May, 2021 regarding clarification on price movement, Vivo Bio Tech has clarified that at present there are no pending announcements that the Company would like to make to the exchange which would have material impact on the Price/ trading volumes in its scrip. The Company believes that the movement in the price/ volume may be purely due to the market conditions and absolutely market driven. The company is always committed to comply with all the requirements of SEBI (LODR) Regulations, 2015 and ensured that in future and when any announcement/ disclosure may be required as per Regulation 30 of the SEBI (LODR) Regulations, 2015 shall be disclosed to stock exchange immediately.

The above information is a part of company’s filings submitted to BSE.

Vivo Bio Tech Share Price

29.30 0.38 (1.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×